Literature DB >> 16293782

Abnormalities in the pulmonary innate immune system in cystic fibrosis.

Theo J Moraes1, Jonathan Plumb, Raiza Martin, Eric Vachon, Vera Cherepanov, Adeline Koh, Carola Loeve, Jenny Jongstra-Bilen, Joanna H Zurawska, Julianne V Kus, Lori L Burrows, Sergio Grinstein, Gregory P Downey.   

Abstract

Pulmonary infection is the dominant clinical feature of cystic fibrosis (CF), but the basis for this susceptibility remains incompletely understood. One hypothesis is that CF airway surface liquid (ASL) is abnormal and interferes with neutrophil function. To study this possibility, we developed an in vitro system in which we collected ASL from primary cultures of normal and CF airway epithelial cells. Microbial killing was less efficient when bacteria were incubated with neutrophils in the presence of ASL from CF epithelia compared with normal ASL. Antimicrobial functions of human neutrophils were assessed in ASL from CF and normal epithelia using a combination of quantitative bacterial culture, flow cytometry, and microfluorescence imaging. The results of these assays of neutrophil function were indistinguishable in CF and normal ASL. In contrast, the direct bactericidal activity of ASL to Escherichia coli and to clinical isolates of Staphylococcus aureus and Pseudomonas aeruginosa was substantially less in CF than in normal ASL, even when highly diluted in media of identical ionic strength. Together, these observations indicate that the antimicrobial properties of ASL in CF are compromised in a manner independent of ionic strength of the ASL, and that this effect is not mediated through a direct effect of the ASL on phagocyte function.

Entities:  

Mesh:

Year:  2005        PMID: 16293782      PMCID: PMC2644201          DOI: 10.1165/rcmb.2005-0146OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  63 in total

1.  Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.

Authors:  R H Lawrence; T C Sorrelli
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

2.  Cystic fibrosis lung inflammation: early, sustained, and severe.

Authors:  A Cantin
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

Review 3.  The neutrophil NADPH oxidase.

Authors:  B M Babior; J D Lambeth; W Nauseef
Journal:  Arch Biochem Biophys       Date:  2002-01-15       Impact factor: 4.013

4.  Early pulmonary inflammation in infants with cystic fibrosis.

Authors:  T Z Khan; J S Wagener; T Bost; J Martinez; F J Accurso; D W Riches
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

5.  Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation.

Authors:  M W Konstan; K A Hilliard; T M Norvell; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

6.  Effects of sodium concentration on human neutrophil bactericidal functions.

Authors:  J P Mizgerd; L Kobzik; A E Warner; J D Brain
Journal:  Am J Physiol       Date:  1995-09

7.  Desensitisation of neutrophil responses by systemic interleukin 8 in cystic fibrosis.

Authors:  Y Dai; T P Dean; M K Church; J O Warner; J K Shute
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

8.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis.

Authors:  K Balough; M McCubbin; M Weinberger; W Smits; R Ahrens; R Fick
Journal:  Pediatr Pulmonol       Date:  1995-08

9.  Potentiation of the oxidative burst of human neutrophils. A signaling role for L-selectin.

Authors:  T K Waddell; L Fialkow; C K Chan; T K Kishimoto; G P Downey
Journal:  J Biol Chem       Date:  1994-07-15       Impact factor: 5.157

10.  Increased degranulation of eosinophil and neutrophil granulocytes in cystic fibrosis.

Authors:  D Y Koller; R Urbanek; M Götz
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

View more
  10 in total

Review 1.  Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury.

Authors:  Rachel L Zemans; Sean P Colgan; Gregory P Downey
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-31       Impact factor: 6.914

2.  Unbiased screening of marine sponge extracts for anti-inflammatory agents combined with chemical genomics identifies girolline as an inhibitor of protein synthesis.

Authors:  Shan-Yu Fung; Vladimir Sofiyev; Julia Schneiderman; Aaron F Hirschfeld; Rachel E Victor; Kate Woods; Jeff S Piotrowski; Raamesh Deshpande; Sheena C Li; Nicole J de Voogd; Chad L Myers; Charlie Boone; Raymond J Andersen; Stuart E Turvey
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

3.  Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome.

Authors:  Jennifer R Peters-Hall; Kristy J Brown; Dinesh K Pillai; Amarel Tomney; Lindsay M Garvin; Xiaofang Wu; Mary C Rose
Journal:  Am J Respir Cell Mol Biol       Date:  2015-07       Impact factor: 6.914

Review 4.  Targeting airway inflammation in cystic fibrosis in children: past, present, and future.

Authors:  Tacjana Pressler
Journal:  Paediatr Drugs       Date:  2011-06-01       Impact factor: 3.022

Review 5.  Role of chemokines in the pathogenesis of acute lung injury.

Authors:  Madhav Bhatia; Rachel L Zemans; Samithamby Jeyaseelan
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

6.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

7.  Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients.

Authors:  Deanna M Green; Kathryn E McDougal; Scott M Blackman; Patrick R Sosnay; Lindsay B Henderson; Kathleen M Naughton; J Michael Collaco; Garry R Cutting
Journal:  Respir Res       Date:  2010-10-08

8.  Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.

Authors:  Robert L Young; Kenneth C Malcolm; Jennifer E Kret; Silvia M Caceres; Katie R Poch; David P Nichols; Jennifer L Taylor-Cousar; Milene T Saavedra; Scott H Randell; Michael L Vasil; Jane L Burns; Samuel M Moskowitz; Jerry A Nick
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

Review 9.  Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.

Authors:  Meraj A Khan; Zubair Sabz Ali; Neil Sweezey; Hartmut Grasemann; Nades Palaniyar
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

10.  The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection.

Authors:  Charaf Benarafa; Gregory P Priebe; Eileen Remold-O'Donnell
Journal:  J Exp Med       Date:  2007-07-30       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.